Some drugs relieve osteoarthritis by activating the NRF2 signaling pathway to reduce inflammation and induce extracellular matrix (ECM) degradation of chondrocytes in vivo and in vitro models of OA (123). Here, NFE2L2 is linked to osteoarthritis.